Royal Perth Hospital — Perth

Public research footprint of Royal Perth Hospital, compiled from the ClinicalTrials.gov public registry.

344

Registered studies

Active

Recruiting now

174

Completed

Stopped or withdrawn

Most-studied conditions

Diffuse Large B-Cell Lymphoma · Essential Thrombocythemia · Metabolic Dysfunction Associated Steatohepatitis (MASH) · Relapsed/Refractory Follicular Lymphoma

Recently updated registry entries

NCT07223593 — Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease (Recruiting)
NCT07623200 — A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… (Recruiting)
NCT06456463 — A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Royal Perth Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.